The Northeastern Satellite Laboratory, or NSL, will be launching a low-cost nanosatellite into low Earth orbit alongside a ...

Trump wants the U.S. to ramp up production of glyphosate. The MAHA movement is furious.

The Supreme Court will examine claims that allege Bayer failed to include a cancer risk warning on its popular weedkiller. If Bayer wins, it could prevent others from suing over the failure to provide ...

Arsenal were reminded just how tough it is to triumph in the latter stages of the Champions League last week, as they were fortunate to escape the first leg of their round of 16 clash with Bayer ...

In an electrifying Bundesliga fixture at the BayArena, Bayer Leverkusen and Bayern München played out a 1-1 draw. The match, a significant one for both teams, was filled with intensity and critical ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Kansas, a key farming state, is considering legislation that would limit lawsuits against companies that produce ...

When Bill Anderson became Bayer’s boss in 2023, shareholders had high hopes that the American would be able to put the German drugs and chemicals firm to rights. Bayer’s $63bn takeover of Monsanto, an ...

A state court judge in Missouri gave an initial green light on Wednesday to a proposed $7.25 billion settlement to resolve thousands of lawsuits claiming Bayer's Roundup weedkiller causes cancer.

Bayer (BAYRY) dropped ~6% on Wednesday after the German conglomerate projected adjusted earnings that fell short of average analysts’ estimates for 2026 as the company eyes a multibillion-dollar ...

Bayer has filed a lawsuit against Johnson & Johnson and Janssen Biotech, alleging the companies made false and misleading claims about the efficacy of its prostate cancer drug Nubeqa compared to the ...

Bayer BAYGn.DE sued Johnson & Johnson JNJ.N on Monday, accusing the drugmaker of falsely advertising a rival multibillion-dollar drug to treat prostate cancer. In a complaint filed in Manhattan ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...